Imaging- and Tumor Biomarker–Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer
Imaging- and Tumor Biomarker–Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer
Nour Abuhadra, Lei Huo, Gary J. Whitman, Gaiane M. Rauch et al.
Journal
JCO Precision Oncology
Topics
Breast Cancer Treatment Studies
article
Imaging- and Tumor Biomarker–Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer
Nour Abuhadra, Lei Huo, Gary J. Whitman, Gaiane M. Rauch, Peng Wei, Anil Korkut, Jennifer K. Litton, Banu Arun, Kelly K. Hunt, Jason B. White, Alastair Mark Thompson, Rania M. Mohamed, Jessica W. T. Leung, Miral Patel, Deanna L. Lane, Stacy L. Moulder, Sanaz Pashapoor, Mary S. Guirguis, Clinton Yam, Rosalind P. Candelaria, Tanya W. Moseley, Beatriz E. Adrada, Huong T. Le‐Petross, Vicente Valero, Wei Yang, Jingfei Ma, Jia Sun, Debu Tripathy
article en
Abstract
No abstract available for this paper.
Publication Tag
JCO Precision OncologyVol. 9(9)
Institutions
Memorial Sloan Kettering Cancer Center (US), The University of Texas MD Anderson Cancer Center (US), Eli Lilly (United States) (US), Baylor College of Medicine (US)